Published in Ann Biomed Eng on April 23, 2009
Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv (2010) 1.08
Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery. Int J Nanomedicine (2012) 0.86
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis (2006) 4.29
Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed Eng (1999) 3.64
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57
Barriers to drug delivery in solid tumors. Sci Am (1994) 3.57
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol (2007) 3.36
Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis (2008) 2.99
Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev (2001) 2.83
Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc (2003) 2.83
Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res (2005) 2.67
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med (2001) 2.18
Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol (2006) 1.94
Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine (Lond) (2007) 1.92
Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation (1999) 1.61
Materials and biology. Nanotechnology takes aim at cancer. Science (2005) 1.61
Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int (2005) 1.51
In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol (2006) 1.51
Nanoparticle probes with surface enhanced Raman spectroscopic tags for cellular cancer targeting. Anal Chem (2006) 1.43
Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy (2005) 1.21
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology (2009) 1.20
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release (2006) 1.19
Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta (1985) 1.18
Inflammatory events in severe acute asthma. Allergy (2005) 1.17
Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther (2006) 1.07
Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials (2008) 1.00
High-throughput identification of phage-derived imaging agents. Mol Imaging (2006) 0.97
Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display. Am J Pathol (2003) 0.95
Cell-specific peptide binding by human neutrophils. Blood (1999) 0.95
Direct fluorochrome labeling of phage display library clones for studying binding specificities: applications in flow cytometry and fluorescence microscopy. J Immunol Methods (2004) 0.92
Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents. Acta Pharmacol Sin (2007) 0.91
A library-selected, Langerhans cell-targeting peptide enhances an immune response. DNA Cell Biol (2004) 0.90
Biomedical nanotechnology for cancer. Med Clin North Am (2007) 0.88
MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma. Nanotechnology (2008) 0.87
Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle. Int J Nanomedicine (2007) 0.87
Neutrophil migration across intestinal epithelium. Ann N Y Acad Sci (2000) 0.85
Targeting leukocytes in immune glomerular diseases. Curr Med Chem (2008) 0.85
Novel G protein-coupled responses in leukocytes elicited by a chemotactic bacteriophage displaying a cell type-selective binding peptide. J Immunol (2001) 0.78
Chronic inflammatory bowel disease--a review. Br J Clin Pract (1983) 0.77
MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell (2003) 4.52
Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol (2003) 4.00
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res (2009) 3.87
MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell (2004) 3.12
Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell (2003) 2.76
JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med (2007) 2.63
Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell (2005) 2.46
Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res (2006) 2.40
Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity (2010) 2.39
Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex. Mol Biol Cell (2005) 2.31
TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol (2007) 2.27
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol (2006) 2.21
Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J (2005) 2.17
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg Infect Dis (2011) 2.11
CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest (2011) 2.08
Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol Biol Cell (2004) 2.05
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood (2005) 1.95
Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem (2005) 1.89
Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med (2004) 1.85
The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps. Biomaterials (2008) 1.80
Implanted neural electrodes cause chronic, local inflammation that is correlated with local neurodegeneration. J Neural Eng (2009) 1.80
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell (2009) 1.73
Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol (2010) 1.73
A unique role for nonmuscle myosin heavy chain IIA in regulation of epithelial apical junctions. PLoS One (2007) 1.72
Topography, cell response, and nerve regeneration. Annu Rev Biomed Eng (2010) 1.70
Implanted neural interfaces: biochallenges and engineered solutions. Annu Rev Biomed Eng (2009) 1.67
Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem (2002) 1.63
Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. Mol Biol Cell (2009) 1.61
Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol Biol Cell (2005) 1.57
Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest (2012) 1.57
Leukocyte-epithelial interactions. Curr Opin Cell Biol (2003) 1.57
Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem (2006) 1.55
Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu Rev Pathol (2007) 1.55
Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays (2005) 1.52
The JAM family of proteins. Adv Drug Deliv Rev (2005) 1.50
Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell (2007) 1.50
Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A (2009) 1.48
In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials (2005) 1.45
Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res (2007) 1.44
Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol (2004) 1.40
DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. J Exp Med (2010) 1.39
The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology (2011) 1.39
Leukocyte transendothelial migration: a junctional affair. Semin Immunol (2002) 1.39
Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). J Immunother (2009) 1.36
Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol (2007) 1.33
CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci (2005) 1.32
Microtubules regulate disassembly of epithelial apical junctions. BMC Cell Biol (2006) 1.31
Biomechanical analysis of silicon microelectrode-induced strain in the brain. J Neural Eng (2005) 1.31
JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell (2004) 1.29
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release (2003) 1.27
Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood (2003) 1.27
Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell (2007) 1.27
Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J Immunol (2008) 1.26
Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem (2004) 1.26
The impact of chronic blood-brain barrier breach on intracortical electrode function. Biomaterials (2013) 1.25
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano (2011) 1.25
The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev (2002) 1.22
Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann N Y Acad Sci (2006) 1.22
Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity (2012) 1.21
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology (2009) 1.20
Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials (2012) 1.20
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release (2006) 1.19
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol (2008) 1.18
Cis-dimerization mediates function of junctional adhesion molecule A. Mol Biol Cell (2008) 1.17
Controlled release of anti-inflammatory agent alpha-MSH from neural implants. J Control Release (2005) 1.17
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med (2006) 1.17
Myosin II regulates the shape of three-dimensional intestinal epithelial cysts. J Cell Sci (2008) 1.16
Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps. Biomaterials (2007) 1.15
Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am J Pathol (2007) 1.15
Nanoscale neuro-integrative coatings for neural implants. Biomaterials (2005) 1.13
Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest (2015) 1.13
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci Transl Med (2012) 1.12
CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans. J Immunol (2002) 1.12
Protein kinase C activation disrupts epithelial apical junctions via ROCK-II dependent stimulation of actomyosin contractility. BMC Cell Biol (2009) 1.11
Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia. J Exp Med (2003) 1.11
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol (2011) 1.10
The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene (2005) 1.10
Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials (2008) 1.09
Association of BAP31 with CD11b/CD18. Potential role in intracellular trafficking of CD11b/CD18 in neutrophils. J Biol Chem (2004) 1.09
Non-muscle myosin IIA differentially regulates intestinal epithelial cell restitution and matrix invasion. Am J Pathol (2009) 1.09
Nanoscale laminin coating modulates cortical scarring response around implanted silicon microelectrode arrays. J Neural Eng (2006) 1.09
Biomaterials for the central nervous system. J R Soc Interface (2008) 1.08
Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells. Mol Biol Cell (2009) 1.08
Anisotropic scaffolds facilitate enhanced neurite extension in vitro. J Biomed Mater Res A (2006) 1.07
Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell (2011) 1.07
Tumor suppressor scribble regulates assembly of tight junctions in the intestinal epithelium. Am J Pathol (2009) 1.07
JAM-A regulates epithelial proliferation through Akt/β-catenin signalling. EMBO Rep (2011) 1.07
Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci (2006) 1.06
Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng (2003) 1.06
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials (2009) 1.06
The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis (2013) 1.05
Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro. Blood (2008) 1.05
Extraction force and cortical tissue reaction of silicon microelectrode arrays implanted in the rat brain. IEEE Trans Biomed Eng (2007) 1.04
Thin-film enhanced nerve guidance channels for peripheral nerve repair. Biomaterials (2009) 1.04
Folate targeting of drug carriers: a mathematical model. J Control Release (2005) 1.04
Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury. Biomaterials (2009) 1.03
Relationship between intracortical electrode design and chronic recording function. Biomaterials (2013) 1.03
Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface. J Immunol (2010) 1.03
The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp (2004) 1.03
Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem Biophys Res Commun (2010) 1.01